{"title": "Handelsblatt auf LinkedIn: Pharmaunternehmen: Biontech startet klinische Studie zu Malaria-Impfstoff | 16 Kommentare", "author": "Ingmar Beck", "url": "https://de.linkedin.com/posts/handelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3", "hostname": "linkedin.com", "description": "Der mRNA-basierte Impfstoff von Biontech k\u00f6nnte die Sterblichkeit durch Malaria reduzieren. In einer Studie soll der Impfstoff nun in drei verschiedenen\u2026 | 16 Kommentare auf LinkedIn", "sitename": "Linkedin", "date": "2022-12-24", "id": null, "license": null, "body": null, "comments": "\u00dcber 25 Jahre Branchenerfahrung \u201eThermen, SPAs und Schwimmb\u00e4der\u201c - Software und Hardware - POS & Zutritt10 Monate\nOb KL dann eine Impfpflicht gegen Malaria f\u00fcr alle dt. B\u00fcrger fordert?", "commentsbody": null, "raw_text": null, "text": "[](https://de.linkedin.com/company/handelsblatt?trk=public_post_feed-actor-image)\n702.562 Follower:innen\nDer mRNA-basierte Impfstoff von Biontech k\u00f6nnte die Sterblichkeit durch Malaria reduzieren. In einer Studie soll der Impfstoff nun in drei verschiedenen Dosisstufen getestet werden.\n[](https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fwww%2Ehandelsblatt%2Ecom%2Ftechnik%2Fforschung-innovation%2Fpharmaunternehmen-biontech-startet-klinische-studie-zu-malaria-impfstoff%2F28888230%2Ehtml%3Futm_term%3Dorganisch%26utm_campaign%3Dstandard%26utm_medium%3Dsm%26utm_content%3Dne%26utm_source%3DLinkedIn&urlhash=qJLe&trk=public_post_feed-article-content)\n[Klaus von Eckartsberg](https://pt.linkedin.com/in/klaus-von-eckartsberg-82434258?trk=public_post_comment_actor-name)10 Monate\nEin neuer Patarollo....?\n[Christoph Welitzki](https://de.linkedin.com/in/christoph-welitzki-3ba26244?trk=public_post_comment_actor-name)9 Monate\nHat ja bei C auch gut funktioniert :-)\n[Matthias Nienhoff](https://de.linkedin.com/in/mfnienhoff?trk=public_post_comment_actor-name)10 Monate\nAls jemand, der die Nebenwirkungen einer Malariaprophylaxe hinter sich hat und in seinem Leben definitiv noch weitere Male in betroffene Regionen reisen wird kann ich nur die Daumen dr\u00fccken. Insbesondere aber deshalb, weil ich wei\u00df, welches Leid diese Krankheit verursacht. Viel Erfolg.\n[Uwe G](https://de.linkedin.com/in/uwe-g-a34354243?trk=public_post_comment_actor-name)10 Monate\n\ud83d\ude0e\ud83d\udc4d\n[Dirk Gormann](https://de.linkedin.com/in/dirk-gormann-3906b93a?trk=public_post_comment_actor-name)10 Monate\nMuss ich dann Covid Impfstoffe nehem?\n[Simon Laufer](https://ch.linkedin.com/in/simon-laufer?trk=public_post_comment_actor-name)10 Monate\nDamit w\u00fcrde es sich um eine Gentherapie im klassischen Wortsinne handeln, sollte der mRNS Wirkstoff nicht die Zellen des Parasiten befallen, was offenkundig nicht der Fall ist.\n[Frank Braun](https://de.linkedin.com/in/frank-braun-58086598?trk=public_post_comment_actor-name)10 Monate\n\"k\u00f6nnte\"............................................. das haben wir schon mal geh\u00f6rt....\n[JAN REH](https://de.linkedin.com/in/jan-reh-b2b5a47a?trk=public_post_comment_actor-name)10 Monate\nmRNA-basiert? OMG.\n[Weitere Kommentare anzeigen](https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_see-more-comments)", "language": null, "image": "https://media.licdn.com/dms/image/D4E34AQE4eZ--Mu1wMg/ugc-proxy-shrink_1280_800/0/1671863429329?e=1699084800&v=beta&t=h9geeTDbTSrIhp8Mq0JFdzlLWtY6RP-lerzY2crZ4Fo", "pagetype": "article", "links": ["https://www.linkedin.com/legal/cookie-policy", "https://www.linkedin.com/mypreferences/g/guest-cookies", "/legal/user-agreement?trk=public_post_google-auth-button_user-agreement", "/legal/privacy-policy?trk=public_post_google-auth-button_privacy-policy", "/legal/cookie-policy?trk=public_post_google-auth-button_cookie-policy", "#main-content", "/?trk=public_post_nav-header-logo", "https://www.linkedin.com/pulse/topics/home/?trk=public_post_guest_nav_menu_articles", "https://www.linkedin.com/pub/dir/+/+?trk=public_post_guest_nav_menu_people", "https://www.linkedin.com/learning/search?trk=public_post_guest_nav_menu_learning", "https://www.linkedin.com/jobs/search?trk=public_post_guest_nav_menu_jobs", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_nav-header-join", "https://www.linkedin.com/login?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&fromSignIn=true&trk=public_post_nav-header-signin", "https://de.linkedin.com/company/handelsblatt?trk=public_post_feed-actor-image", "https://de.linkedin.com/company/handelsblatt?trk=public_post_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fwww%2Ehandelsblatt%2Ecom%2Ftechnik%2Fforschung-innovation%2Fpharmaunternehmen-biontech-startet-klinische-studie-zu-malaria-impfstoff%2F28888230%2Ehtml%3Futm_term%3Dorganisch%26utm_campaign%3Dstandard%26utm_medium%3Dsm%26utm_content%3Dne%26utm_source%3DLinkedIn&urlhash=qJLe&trk=public_post_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_social-actions-comments", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment-cta", "https://de.linkedin.com/in/ingmar-beck-a6b51814b?trk=public_post_comment_actor-image", "https://de.linkedin.com/in/ingmar-beck-a6b51814b?trk=public_post_comment_actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=COMMENT&_f=guest-reporting", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_like", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_reply", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_reactions", "https://pt.linkedin.com/in/klaus-von-eckartsberg-82434258?trk=public_post_comment_actor-image", "https://pt.linkedin.com/in/klaus-von-eckartsberg-82434258?trk=public_post_comment_actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=COMMENT&_f=guest-reporting", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_like", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_reply", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_reactions", "https://de.linkedin.com/in/christoph-welitzki-3ba26244?trk=public_post_comment_actor-image", "https://de.linkedin.com/in/christoph-welitzki-3ba26244?trk=public_post_comment_actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=COMMENT&_f=guest-reporting", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_like", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_reply", "https://de.linkedin.com/in/mfnienhoff?trk=public_post_comment_actor-image", "https://de.linkedin.com/in/mfnienhoff?trk=public_post_comment_actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=COMMENT&_f=guest-reporting", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_like", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_reply", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_reactions", "https://de.linkedin.com/in/uwe-g-a34354243?trk=public_post_comment_actor-image", "https://de.linkedin.com/in/uwe-g-a34354243?trk=public_post_comment_actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=COMMENT&_f=guest-reporting", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_like", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_reply", "https://de.linkedin.com/in/dirk-gormann-3906b93a?trk=public_post_comment_actor-image", "https://de.linkedin.com/in/dirk-gormann-3906b93a?trk=public_post_comment_actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=COMMENT&_f=guest-reporting", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_like", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_reply", "https://ch.linkedin.com/in/simon-laufer?trk=public_post_comment_actor-image", "https://ch.linkedin.com/in/simon-laufer?trk=public_post_comment_actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=COMMENT&_f=guest-reporting", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_like", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_reply", "https://de.linkedin.com/in/frank-braun-58086598?trk=public_post_comment_actor-image", "https://de.linkedin.com/in/frank-braun-58086598?trk=public_post_comment_actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=COMMENT&_f=guest-reporting", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_like", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_reply", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_reactions", "https://de.linkedin.com/in/jan-reh-b2b5a47a?trk=public_post_comment_actor-image", "https://de.linkedin.com/in/jan-reh-b2b5a47a?trk=public_post_comment_actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=COMMENT&_f=guest-reporting", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_like", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_reply", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_comment_reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_see-more-comments", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Fposts%2Fhandelsblatt_pharmaunternehmen-biontech-startet-klinische-activity-7012303462558269440-t_D3&trk=public_post_feed-cta-banner-cta", "https://de.linkedin.com/posts/handelsblatt_bundesbank-nagel-straffe-geldpolitik-der-activity-7123926553624764417-3oYa", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-image", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_bundesbank-nagel-straffe-geldpolitik-der-activity-7123926553624764417-3oYa&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fwww%2Ehandelsblatt%2Ecom%2Ffinanzen%2Fgeldpolitik%2Fbundesbank-nagel-straffe-geldpolitik-der-ezb-wirkt%2F29469830%2Ehtml%3Futm_term%3Dorganisch%26utm_campaign%3Dstandard%26utm_medium%3Dsm%26utm_content%3Dne%26utm_source%3DLinkedIn&urlhash=bdX5&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_bundesbank-nagel-straffe-geldpolitik-der-activity-7123926553624764417-3oYa&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_bundesbank-nagel-straffe-geldpolitik-der-activity-7123926553624764417-3oYa&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_bundesbank-nagel-straffe-geldpolitik-der-activity-7123926553624764417-3oYa&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://de.linkedin.com/posts/handelsblatt_usa-t%C3%B6dliche-bluttat-in-maine-leiche-des-activity-7123920924642324480-72UW", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-image", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_usa-t%25C3%25B6dliche-bluttat-in-maine-leiche-des-activity-7123920924642324480-72UW&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fwww%2Ehandelsblatt%2Ecom%2Fpolitik%2Finternational%2Fusa-toedliche-bluttat-in-maine-leiche-des-mutmasslichen-schuetzen-gefunden%2F29470612%2Ehtml&urlhash=mkei&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_usa-t%25C3%25B6dliche-bluttat-in-maine-leiche-des-activity-7123920924642324480-72UW&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_usa-t%25C3%25B6dliche-bluttat-in-maine-leiche-des-activity-7123920924642324480-72UW&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_usa-t%25C3%25B6dliche-bluttat-in-maine-leiche-des-activity-7123920924642324480-72UW&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_usa-t%25C3%25B6dliche-bluttat-in-maine-leiche-des-activity-7123920924642324480-72UW&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://de.linkedin.com/posts/handelsblatt_immobilienprojekt-signa-gruppe-ist-laut-activity-7123910921776721920-9UYa", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-image", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_immobilienprojekt-signa-gruppe-ist-laut-activity-7123910921776721920-9UYa&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fwww%2Ehandelsblatt%2Ecom%2Funternehmen%2Fhandel-konsumgueter%2Fimmobilienprojekt-signa-gruppe-ist-laut-bauunternehmen-lupp-beim-elbtower-in-zahlungsverzug%2F29469662%2Ehtml%3Futm_term%3Dorganisch%26utm_campaign%3Dstandard%26utm_medium%3Dsm%26utm_content%3Dne%26utm_source%3DLinkedIn&urlhash=uJVj&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_immobilienprojekt-signa-gruppe-ist-laut-activity-7123910921776721920-9UYa&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_immobilienprojekt-signa-gruppe-ist-laut-activity-7123910921776721920-9UYa&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_immobilienprojekt-signa-gruppe-ist-laut-activity-7123910921776721920-9UYa&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_immobilienprojekt-signa-gruppe-ist-laut-activity-7123910921776721920-9UYa&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://de.linkedin.com/posts/handelsblatt_galeria-chef-im-interview-in-den-filialen-activity-7123901048779362305-Eudn", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-image", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_galeria-chef-im-interview-in-den-filialen-activity-7123901048779362305-Eudn&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fwww%2Ehandelsblatt%2Ecom%2Funternehmen%2Fhandel-konsumgueter%2Fgaleria-chef-im-interview-in-den-filialen-machen-wir-operativ-gewinn%2F29467430%2Ehtml%3Futm_term%3Dorganisch%26utm_campaign%3Dstandard%26utm_medium%3Dsm%26utm_content%3Dne%26utm_source%3DLinkedIn&urlhash=jsZn&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_galeria-chef-im-interview-in-den-filialen-activity-7123901048779362305-Eudn&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_galeria-chef-im-interview-in-den-filialen-activity-7123901048779362305-Eudn&trk=public_post_main-feed-card_social-actions-comments", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_galeria-chef-im-interview-in-den-filialen-activity-7123901048779362305-Eudn&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_galeria-chef-im-interview-in-den-filialen-activity-7123901048779362305-Eudn&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_galeria-chef-im-interview-in-den-filialen-activity-7123901048779362305-Eudn&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://de.linkedin.com/posts/handelsblatt_autonomes-fahren-gm-stoppt-betrieb-mit-autonomen-activity-7123882532093227009-VUZ3", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-image", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_autonomes-fahren-gm-stoppt-betrieb-mit-autonomen-activity-7123882532093227009-VUZ3&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fwww%2Ehandelsblatt%2Ecom%2Funternehmen%2Findustrie%2Fautonomes-fahren-gm-stoppt-betrieb-mit-autonomen-taxis-behoerden-ermitteln%2F29469252%2Ehtml%3Futm_term%3Dorganisch%26utm_campaign%3Dstandard%26utm_medium%3Dsm%26utm_content%3Dne%26utm_source%3DLinkedIn&urlhash=q2Zf&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_autonomes-fahren-gm-stoppt-betrieb-mit-autonomen-activity-7123882532093227009-VUZ3&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_autonomes-fahren-gm-stoppt-betrieb-mit-autonomen-activity-7123882532093227009-VUZ3&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_autonomes-fahren-gm-stoppt-betrieb-mit-autonomen-activity-7123882532093227009-VUZ3&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_autonomes-fahren-gm-stoppt-betrieb-mit-autonomen-activity-7123882532093227009-VUZ3&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://de.linkedin.com/posts/handelsblatt_medienbericht-google-investiert-milliardensumme-activity-7123870025211392002-3ECV", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-image", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_medienbericht-google-investiert-milliardensumme-activity-7123870025211392002-3ECV&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fwww%2Ehandelsblatt%2Ecom%2Ftechnik%2Fit-internet%2Fmedienbericht-google-investiert-milliardensumme-in-ki-startup-anthropic%2F29470580%2Ehtml&urlhash=nNW1&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_medienbericht-google-investiert-milliardensumme-activity-7123870025211392002-3ECV&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_medienbericht-google-investiert-milliardensumme-activity-7123870025211392002-3ECV&trk=public_post_main-feed-card_social-actions-comments", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_medienbericht-google-investiert-milliardensumme-activity-7123870025211392002-3ECV&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_medienbericht-google-investiert-milliardensumme-activity-7123870025211392002-3ECV&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_medienbericht-google-investiert-milliardensumme-activity-7123870025211392002-3ECV&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://de.linkedin.com/posts/handelsblatt_us-st%C3%BCtzpunkte-aktivisten-erneut-angriffe-activity-7123864986090680320-R0TG", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-image", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_us-st%25C3%25BCtzpunkte-aktivisten-erneut-angriffe-activity-7123864986090680320-R0TG&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fwww%2Ehandelsblatt%2Ecom%2Fpolitik%2Finternational%2Fus-stuetzpunkte-aktivisten-erneut-angriffe-auf-us-truppen-in-syrien-%2F29470564%2Ehtml&urlhash=MYxh&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_us-st%25C3%25BCtzpunkte-aktivisten-erneut-angriffe-activity-7123864986090680320-R0TG&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_us-st%25C3%25BCtzpunkte-aktivisten-erneut-angriffe-activity-7123864986090680320-R0TG&trk=public_post_main-feed-card_social-actions-comments", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_us-st%25C3%25BCtzpunkte-aktivisten-erneut-angriffe-activity-7123864986090680320-R0TG&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_us-st%25C3%25BCtzpunkte-aktivisten-erneut-angriffe-activity-7123864986090680320-R0TG&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_us-st%25C3%25BCtzpunkte-aktivisten-erneut-angriffe-activity-7123864986090680320-R0TG&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://de.linkedin.com/posts/handelsblatt_luftfahrt-lufthansa-braucht-mehr-als-2000-activity-7123858778688532480-93sG", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-image", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_luftfahrt-lufthansa-braucht-mehr-als-2000-activity-7123858778688532480-93sG&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fwww%2Ehandelsblatt%2Ecom%2Funternehmen%2Fhandel-konsumgueter%2Fluftfahrt-lufthansa-braucht-mehr-als-2000-neue-piloten-bis-2025%2F29469686%2Ehtml%3Futm_term%3Dorganisch%26utm_campaign%3Dstandard%26utm_medium%3Dsm%26utm_content%3Dne%26utm_source%3DLinkedIn&urlhash=3grV&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_luftfahrt-lufthansa-braucht-mehr-als-2000-activity-7123858778688532480-93sG&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_luftfahrt-lufthansa-braucht-mehr-als-2000-activity-7123858778688532480-93sG&trk=public_post_main-feed-card_social-actions-comments", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_luftfahrt-lufthansa-braucht-mehr-als-2000-activity-7123858778688532480-93sG&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_luftfahrt-lufthansa-braucht-mehr-als-2000-activity-7123858778688532480-93sG&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_luftfahrt-lufthansa-braucht-mehr-als-2000-activity-7123858778688532480-93sG&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://de.linkedin.com/posts/handelsblatt_kommentar-der-lieferdienst-mein-aldi-kommt-activity-7123847100513071106-aT3e", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-image", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_kommentar-der-lieferdienst-mein-aldi-kommt-activity-7123847100513071106-aT3e&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fwww%2Ehandelsblatt%2Ecom%2Fmeinung%2Fkommentare%2Fkommentar-der-lieferdienst-mein-aldi-kommt-genau-zur-richtigen-zeit%2F29354756%2Ehtml%3Futm_term%3Dorganisch%26utm_campaign%3Dstandard%26utm_medium%3Dsm%26utm_content%3Dne%26utm_source%3DLinkedIn&urlhash=phGu&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_kommentar-der-lieferdienst-mein-aldi-kommt-activity-7123847100513071106-aT3e&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_kommentar-der-lieferdienst-mein-aldi-kommt-activity-7123847100513071106-aT3e&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_kommentar-der-lieferdienst-mein-aldi-kommt-activity-7123847100513071106-aT3e&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_kommentar-der-lieferdienst-mein-aldi-kommt-activity-7123847100513071106-aT3e&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://de.linkedin.com/posts/handelsblatt_lindner-nach-steuersch%C3%A4tzung-neue-verteilungsspielr%C3%A4ume-activity-7123837434349432833-IBmj", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-image", "https://de.linkedin.com/company/handelsblatt?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_lindner-nach-steuersch%25C3%25A4tzung-neue-verteilungsspielr%25C3%25A4ume-activity-7123837434349432833-IBmj&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fwww%2Ehandelsblatt%2Ecom%2Fvideo%2Fpolitik%2Ffinanzmaerkte-lindner-nach-steuerschaetzung-neue-verteilungsspielraeume-gibt-es-nicht%2F29469706%2Ehtml%3Futm_term%3Dorganisch%26utm_campaign%3Dstandard%26utm_medium%3Dsm%26utm_content%3Dne%26utm_source%3DLinkedIn&urlhash=4AYc&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_lindner-nach-steuersch%25C3%25A4tzung-neue-verteilungsspielr%25C3%25A4ume-activity-7123837434349432833-IBmj&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_lindner-nach-steuersch%25C3%25A4tzung-neue-verteilungsspielr%25C3%25A4ume-activity-7123837434349432833-IBmj&trk=public_post_main-feed-card_social-actions-comments", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_lindner-nach-steuersch%25C3%25A4tzung-neue-verteilungsspielr%25C3%25A4ume-activity-7123837434349432833-IBmj&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_lindner-nach-steuersch%25C3%25A4tzung-neue-verteilungsspielr%25C3%25A4ume-activity-7123837434349432833-IBmj&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde.linkedin.com%2Fposts%2Fhandelsblatt_lindner-nach-steuersch%25C3%25A4tzung-neue-verteilungsspielr%25C3%25A4ume-activity-7123837434349432833-IBmj&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://de.linkedin.com/company/handelsblatt?trk=public_post_follow-view-profile", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fde%2Elinkedin%2Ecom%2Ffeed%2Fupdate%2Furn%3Ali%3Aactivity%3A7012303462558269440&trk=public_post_follow", "https://de.linkedin.com/pulse/handelsblatt-ki-briefing-die-zahlen-der-tech-giganten-handelsblatt-gc5ee?trk=public_post", "https://de.linkedin.com/pulse/sieben-profi-anleger-berichten-welche-fehler-sie-nicht-mehr-xsr3e?trk=public_post", "https://de.linkedin.com/pulse/handelsblatt-ki-briefing-wie-die-fdp-mit-ki-politik-machen-sekne?trk=public_post", "https://about.linkedin.com?trk=d_public_post_footer-about", "https://www.linkedin.com/accessibility?trk=d_public_post_footer-accessibility", "https://www.linkedin.com/legal/user-agreement?trk=d_public_post_footer-user-agreement", "https://www.linkedin.com/legal/privacy-policy?trk=d_public_post_footer-privacy-policy", "https://www.linkedin.com/legal/cookie-policy?trk=d_public_post_footer-cookie-policy", "https://www.linkedin.com/legal/copyright-policy?trk=d_public_post_footer-copyright-policy", "https://brand.linkedin.com/policies?trk=d_public_post_footer-brand-policy", "https://www.linkedin.com/psettings/guest-controls?trk=d_public_post_footer-guest-controls", "https://www.linkedin.com/legal/professional-community-policies?trk=d_public_post_footer-community-guide", null]}